VF
LENZ

Virtu Financial’s LENZ Therapeutics LENZ Stock Holding History

Virtu Financial’s Portfolio LENZ Stock Details LENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$352K Buy
38,520
+26,173
+212% +$368K 0.01% 738
2025
Q4 		$198K Buy
+12,347
New +$360K 0.01% 1028
2024
Q1 		– Sell
-4,985
Closed -$91K – 2202
2023
Q4 		$91K Buy
+4,985
New +$82.3K 0.01% 1050
2021
Q3 		– Sell
-1,101
Closed -$237K – 2041
2021
Q2 		$237K Buy
+1,101
New +$192K 0.02% 872

Other funds holding LENZ

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
7IH
72 Investment Holdings Stamford, Connecticut $49.6M AUM 684.72% 1-Year Est. Return

Virtu Financial's LENZ Position: Q1 2026 in Review

Virtu Financial increased its LENZ Therapeutics (LENZ) stake by 212% in Q1 2026, buying an estimated $368K and bringing the position to 38,520 shares worth $352K. The position accounts for 0.01% of the portfolio, ranked #738.

Virtu Financial first reported a position in LENZ in Q2 2021 and has held it in 4 quarters since. 145 funds tracked by Wall St. Rank hold LENZ as of Q1 2026.

  • Virtu Financial held 38,520 shares of LENZ Therapeutics worth $352K as of Q1 2026.
  • Virtu Financial bought 26,173 LENZ Therapeutics shares in Q1 2026, an estimated $368K.
  • LENZ Therapeutics made up 0.01% of Virtu Financial's portfolio in Q1 2026, its #738 holding.
  • Virtu Financial first reported a position in LENZ Therapeutics in Q2 2021 and has held it in 4 quarters since.
  • 145 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.